Back

Septal left ventricular hypertrophy: the role of cardiac magnetic resonance and feature tracking to distinguish hypertrophic cardiomyopathy from hypertensive heart disease

13 December 2025 (08:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Poster session 3 Myocardial Disease EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Silvia Malara

Humanitas Gavazzeni Hospital, Bergamo (Italy)

71 More presentations in this session

Presentation thumbnail
Association between left atrial mechanics parameters and long-term heart failure hospitalizations in a cohort of patients with atrial fibrillation
Doctor L. Barriales (Lima, PE)
Abstract Slides
Presentation thumbnail
Evaluation of myocardial work during exercise echocardiography in a healthy population
Doctor A. Baptista Carvalho (Vila Franca de Xira, PT)
Abstract
Presentation thumbnail
Combined assessment of mechanical dispersion and global wasted work enhances risk prediction in acute ST-segment elevation myocardial infarction patients
Doctor A. Frisan (Timisoara, RO)
Abstract Slides
Presentation thumbnail
The influence of resting, exercise-induced hypertension and cardiac remodeling on myocardial work indices
Doctor A. Baptista Carvalho (Vila Franca de Xira, PT)
Abstract
Presentation thumbnail
The prognostic role of global longitudinal strain in heart failure: exploring beyond ejection fraction
Doctor I. Amorim Cruz (Aveiro, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3

The Event

Event poster

EACVI 2025

13 December 2025 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Gender differences in hypertrophic cardiomyopathy assessed by cardiovascular magnetic resonance feature tracking
thumbnail
Congress Presentation
Three-dimensional feature tracking cardiac magnetic resonance in hypertrophic cardiomyopathy: comparison with two-dimensional algorithm
thumbnail
Congress Presentation
Left atrial strain identifies low-risk hypertrophic cardiomyopathy patients: a CMR study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources